Optimized production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair for nuclear medicine
Abstract TRIUMF is one of the only laboratories in the world able to produce both lead-203 (203Pb, t1/2 = 51.9 h) and 212Pb (t1/2 = 10.6 h) onsite via its 13 and 500 MeV cyclotrons, respectively. Together, 203Pb and 212Pb form an element-equivalent theranostic pair that potentiate image-guided, pers...
Main Authors: | Brooke L. McNeil, Simona A. Mastroianni, Scott W. McNeil, Stefan Zeisler, Joel Kumlin, Sogol Borjian, Anthony W. McDonagh, Michael Cross, Paul Schaffer, Caterina F. Ramogida |
---|---|
Format: | Article |
Language: | English |
Published: |
Nature Portfolio
2023-06-01
|
Series: | Scientific Reports |
Online Access: | https://doi.org/10.1038/s41598-023-37313-8 |
Similar Items
-
Production, purification, and radiolabeling of the 203Pb/212Pb theranostic pair
by: Brooke L. McNeil, et al.
Published: (2021-02-01) -
Synthesis of DOTA-pyridine chelates for 64Cu coordination and radiolabeling of αMSH peptide
by: Hua Yang, et al.
Published: (2021-01-01) -
Development of a multi faceted platform containing a tetrazine, fluorophore and chelator: synthesis, characterization, radiolabeling, and immuno-SPECT imaging
by: Anthony W. McDonagh, et al.
Published: (2022-06-01) -
A Theranostic Approach to Imaging and Treating Melanoma with <sup>203</sup>Pb/<sup>212</sup>Pb-Labeled Antibody Targeting Melanin
by: Rubin Jiao, et al.
Published: (2023-07-01) -
Preclinical Evaluation of a Lead Specific Chelator (PSC) Conjugated to Radiopeptides for <sup>203</sup>Pb and <sup>212</sup>Pb-Based Theranostics
by: Mengshi Li, et al.
Published: (2023-01-01)